SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-187155
Filing Date
2013-04-30
Accepted
2013-04-30 16:06:01
Documents
2
Period of Report
2013-06-26
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d478032ddef14a.htm DEF 14A 741685
2 GRAPHIC g478032g22s00.jpg GRAPHIC 24382
  Complete submission text file 0001193125-13-187155.txt   776592
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34921 | Film No.: 13797478
SIC: 2834 Pharmaceutical Preparations